Back to Search Start Over

alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice.

Authors :
Fagerholm, V.
Scheinin, M.
Haaparanta, M.
Source :
British Journal of Pharmacology; Jul2008, Vol. 154 Issue 6, p1287-1296, 10p, 1 Diagram, 4 Graphs
Publication Year :
2008

Abstract

Background and purpose:The imidazoline-type α<subscript>2</subscript>-adrenoceptor antagonists (±)-efaroxan and phentolamine increase insulin secretion and reduce blood glucose levels. It is not known whether they act by antagonizing pancreatic β-cell α<subscript>2</subscript>-adrenoceptors or by α<subscript>2</subscript>-adrenoceptor-independent mechanisms. Many imidazolines inhibit the pancreatic β-cell K<subscript>ATP</subscript> channel, which is the molecular target of sulphonylurea drugs used in the treatment of type II diabetes. To investigate the mechanisms of action of (±)-efaroxan and phentolamine, α<subscript>2A</subscript>-adrenoceptor knockout (α<subscript>2A</subscript>-KO) mice were used.Experimental approach:Effects of (±)-efaroxan, 5 mg kg<superscript>−1</superscript>, and phentolamine, 1 mg kg<superscript>−1</superscript>, on blood glucose and insulin levels were compared with those of the non-imidazoline α<subscript>2</subscript>-adrenoceptor antagonist [8aR,12aS,13aS]-5,8,8a,9,10,11,12,12a,13,13a-decahydro-3-methoxy-12-(ethylsulphonyl)-6H-isoquino[2,1-g][1,6]naphthyridine (RS79948-197), 1 mg kg<superscript>−1</superscript>, and the sulphonylurea glibenclamide, in α<subscript>2A</subscript>-KO and control (wild type (WT)) mice.Key results:In fed WT mice, (±)-efaroxan, phentolamine and RS79948-197 reduced blood glucose and increased insulin levels. Fasting abolished these effects. In fed α<subscript>2A</subscript>-KO mice, (±)-efaroxan, phentolamine and RS79948-197 did not alter blood glucose or insulin levels, and in fasted α<subscript>2A</subscript>-KO mice, blood glucose levels were increased. Glibenclamide, at a dose only moderately efficacious in WT mice (5 mg kg<superscript>−1</superscript>), caused severe hyperinsulinaemia and hypoglycaemia in α<subscript>2A</subscript>-KO mice. This was mimicked in WT mice by co-administration of RS79948-197 with glibenclamide.Conclusions and implications:These results suggest that (±)-efaroxan and phentolamine increase insulin secretion by inhibition of β-cell α<subscript>2A</subscript>-adrenoceptors, and demonstrate a critical role for α<subscript>2A</subscript>-adrenoceptors in limiting sulphonylurea-induced hyperinsulinaemia and hypoglycaemia.British Journal of Pharmacology (2008) 154, 1287–1296; doi:10.1038/bjp.2008.186; published online 19 May 2008 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00071188
Volume :
154
Issue :
6
Database :
Complementary Index
Journal :
British Journal of Pharmacology
Publication Type :
Academic Journal
Accession number :
33137973
Full Text :
https://doi.org/10.1038/bjp.2008.186